Cross-talk between insulin signaling and GPCRs

Qin Fu, Qian Shi, Toni M. West, Yang Kevin Xiang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

ABSTRACT: Diabetes is a major risk factor for the development of heart failure. One of the hallmarks of diabetes is insulin resistance associated with hyperinsulinemia. The literature shows that insulin and adrenergic signaling is intimately linked to each other; however, whether and how insulin may modulate cardiac adrenergic signaling and cardiac function remains unknown. Notably, recent studies have revealed that insulin receptor and β2 adrenergic receptor (β2AR) forms a membrane complex in animal hearts, bringing together the direct contact between two receptor signaling systems, and forming an integrated and dynamic network. Moreover, insulin can drive cardiac adrenergic desensitization via PKA and GRK phosphorylation of the β2AR, which compromises adrenergic regulation of cardiac contractile function. In this review, we will explore the current state of knowledge linking insulin and GPCR signaling, especially βAR signaling in the heart, with emphasis on molecular insights regarding its role in diabetic cardiomyopathy (DCM).

Original languageEnglish (US)
JournalJournal of Cardiovascular Pharmacology
DOIs
StateAccepted/In press - Mar 17 2017

Fingerprint

Adrenergic Agents
Insulin
Adrenergic Receptors
Diabetic Cardiomyopathies
Insulin Receptor
Hyperinsulinism
Insulin Resistance
Heart Failure
Phosphorylation
Membranes

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Cross-talk between insulin signaling and GPCRs. / Fu, Qin; Shi, Qian; West, Toni M.; Xiang, Yang Kevin.

In: Journal of Cardiovascular Pharmacology, 17.03.2017.

Research output: Contribution to journalArticle

@article{8b9574e877e241efb794e846a06e649f,
title = "Cross-talk between insulin signaling and GPCRs",
abstract = "ABSTRACT: Diabetes is a major risk factor for the development of heart failure. One of the hallmarks of diabetes is insulin resistance associated with hyperinsulinemia. The literature shows that insulin and adrenergic signaling is intimately linked to each other; however, whether and how insulin may modulate cardiac adrenergic signaling and cardiac function remains unknown. Notably, recent studies have revealed that insulin receptor and β2 adrenergic receptor (β2AR) forms a membrane complex in animal hearts, bringing together the direct contact between two receptor signaling systems, and forming an integrated and dynamic network. Moreover, insulin can drive cardiac adrenergic desensitization via PKA and GRK phosphorylation of the β2AR, which compromises adrenergic regulation of cardiac contractile function. In this review, we will explore the current state of knowledge linking insulin and GPCR signaling, especially βAR signaling in the heart, with emphasis on molecular insights regarding its role in diabetic cardiomyopathy (DCM).",
author = "Qin Fu and Qian Shi and West, {Toni M.} and Xiang, {Yang Kevin}",
year = "2017",
month = "3",
day = "17",
doi = "10.1097/FJC.0000000000000481",
language = "English (US)",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Cross-talk between insulin signaling and GPCRs

AU - Fu, Qin

AU - Shi, Qian

AU - West, Toni M.

AU - Xiang, Yang Kevin

PY - 2017/3/17

Y1 - 2017/3/17

N2 - ABSTRACT: Diabetes is a major risk factor for the development of heart failure. One of the hallmarks of diabetes is insulin resistance associated with hyperinsulinemia. The literature shows that insulin and adrenergic signaling is intimately linked to each other; however, whether and how insulin may modulate cardiac adrenergic signaling and cardiac function remains unknown. Notably, recent studies have revealed that insulin receptor and β2 adrenergic receptor (β2AR) forms a membrane complex in animal hearts, bringing together the direct contact between two receptor signaling systems, and forming an integrated and dynamic network. Moreover, insulin can drive cardiac adrenergic desensitization via PKA and GRK phosphorylation of the β2AR, which compromises adrenergic regulation of cardiac contractile function. In this review, we will explore the current state of knowledge linking insulin and GPCR signaling, especially βAR signaling in the heart, with emphasis on molecular insights regarding its role in diabetic cardiomyopathy (DCM).

AB - ABSTRACT: Diabetes is a major risk factor for the development of heart failure. One of the hallmarks of diabetes is insulin resistance associated with hyperinsulinemia. The literature shows that insulin and adrenergic signaling is intimately linked to each other; however, whether and how insulin may modulate cardiac adrenergic signaling and cardiac function remains unknown. Notably, recent studies have revealed that insulin receptor and β2 adrenergic receptor (β2AR) forms a membrane complex in animal hearts, bringing together the direct contact between two receptor signaling systems, and forming an integrated and dynamic network. Moreover, insulin can drive cardiac adrenergic desensitization via PKA and GRK phosphorylation of the β2AR, which compromises adrenergic regulation of cardiac contractile function. In this review, we will explore the current state of knowledge linking insulin and GPCR signaling, especially βAR signaling in the heart, with emphasis on molecular insights regarding its role in diabetic cardiomyopathy (DCM).

UR - http://www.scopus.com/inward/record.url?scp=85015976956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015976956&partnerID=8YFLogxK

U2 - 10.1097/FJC.0000000000000481

DO - 10.1097/FJC.0000000000000481

M3 - Article

C2 - 28328746

AN - SCOPUS:85015976956

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

ER -